We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Microfiber Pad Helps Collect Uncontaminated Urine Samples

By LabMedica International staff writers
Posted on 27 Jan 2016
A new noninvasive microfiber pad draws urine samples in seconds, preventing cross-contamination during collection.

Developed by researchers of the BioDesign team at the Hebrew University (HUJI; Jerusalem, Israel) and Hadassah Medical Center (Jerusalem, Israel), the UCap microfiber urine collection pad contains bundles of hollow glass microfibers that quickly draw urine via capillary action from absorptive pads in just seconds. More...
The remainder of the urine is absorbed by a polymer matrix, thus preventing cross-contamination of the urine sample by contact with the patient’s skin or fecal matter.

The low-cost but highly effective solution can save time and money in the collection of sterile samples from patients especially prone to contract a urinary tract infection (UTI), including infants and bed-ridden hospitalized patients. While sterile urine samples can be readily collected in adults using simple plastic cups, urine collections in infants and hospitalized populations relies on adhesive plastic bags or on invasive catheters.

“Contamination of urine samples from infants and the elderly is so common that physicians often needlessly prescribe broad-spectrum antibiotics prophylactically, increasing the risk of developing antibiotic resistant bacteria,” said Amir Orlev, MD, who was part of the multidisciplinary BioDesign team set out to solve the problem under a medical innovation program.

“More than 11 million urine tests are carried out each year in infants and elderly patients. This presents a market of USD 100 million annually in the United States alone,” said BioDesign team member MBA student Itai Monnickendam. “Our low-cost urine collection pad has the potential to reduce pain and complications for millions of people and save time and expenditure for the healthcare system.”

Related Links:

Hebrew University of Jerusalem
Hadassah Medical Center



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.